Fenimore Christopher R. 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed Aug 29, 2024
Insider Transaction Report
Form 4
Fenimore Christopher R.
VP, Controller
Transactions
- Sale
Common Stock
2024-08-28$1204.79/sh−228$274,692→ 966 total(indirect: 2021 GRAT) - Sale
Common Stock
2024-08-28$1206.30/sh−200$241,260→ 0 total(indirect: 2021 GRAT) - Sale
Common Stock
2024-08-28$1205.67/sh−235$283,332→ 225 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1204.71/sh−2,237$2,694,936→ 1,378 total(indirect: 2022 GRAT) - Sale
Common Stock
2024-08-28$1205.49/sh−928$1,118,695→ 450 total(indirect: 2022 GRAT) - Sale
Common Stock
2024-08-28$1205.67/sh−236$284,538→ 225 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1206.70/sh−200$241,340→ 25 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1205.44/sh−766$923,367→ 200 total(indirect: 2021 GRAT) - Sale
Common Stock
2024-08-28$1206.67/sh−200$241,334→ 25 total(indirect: By Trust) - Sale
Common Stock
2024-08-28$1206.15/sh−450$542,768→ 0 total(indirect: 2022 GRAT)
Holdings
- 15,305
Common Stock
- 1,897(indirect: By Trust)
Common Stock
- 1,515(indirect: By 401(k))
Common Stock
Footnotes (11)
- [F1]Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F10]Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F11]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
- [F2]Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F3]Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F4]Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F5]Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F6]Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F7]Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F8]Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- [F9]Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.